Vince Holding Corp. (VNCE) — Earnings Call X-Ray
Our AI read all 35 of VNCE's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
F
Q4 2024
Calls Analyzed
35
2016–2025
Avg Candor
6.6/9
evasion 2.2/9
Call-by-call analysis
🔒 Q1 2025 earnings call
2025-06-17
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q1 2025 call grade is ready
The full 37-point AI read of VNCE's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
F
Q4 2024 earnings call
2025-05-02
Management gave no formal guidance. The delivery was guarded, light on specifics, relaxed under questioning.
✓ Clean call⚑ Question left hanging
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
B
Q3 2024 earnings call
2024-12-10
Management held guidance steady against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics.
Guidance: maintainedDemand: mixedMargins: expandingPricing: stableCapex: increasing 1 analysts · 3 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsCFO dominatesDirection beats results
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C+
Q2 2024 earnings call
2024-09-16
Management gave no formal guidance against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.
Guidance: mixedDemand: stableMargins: expandingPricing: raisingHeadcount: cuttingCapex: flat 2 analysts · 6 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Resolves doubts⚑ Reads rehearsedHidden segmentCFO dominates
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
C+
Q1 2024 earnings call
2024-06-18
Management held guidance steady against mixed demand signals and expanding margins. The delivery was rich in specifics.
Guidance: maintainedDemand: mixedMargins: expandingBacklog: stablePricing: raisingHeadcount: cutting 2 analysts · 7 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsedCFO dominates
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
C
Q4 2023 earnings call
2024-04-30
Management held guidance steady against slowing demand and expanding margins. The delivery was unusually candid, rich in specifics.
Guidance: maintainedDemand: slowingMargins: expandingPricing: stableHeadcount: cuttingCapex: flat
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedCFO dominatesDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
C
Q3 2023 earnings call
2023-12-06
Management gave no formal guidance against slowing demand and expanding margins. The delivery was rich in specifics.
Demand: slowingMargins: expandingPricing: raising
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedHidden segmentDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
C
Q2 2023 earnings call
2023-09-12
Management gave no formal guidance against slowing demand and expanding margins. The delivery was unusually candid, rich in specifics.
Demand: slowingMargins: expandingHeadcount: flat
⚑ Critic ammunition⚑ Question left hanging✓ Resolves doubts⚑ Reads rehearsedDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q1 2023 |
2023-06-08 |
C |
none | slowing | stable |
6/9 |
2/9 |
| Q4 2022 |
2023-04-29 |
C |
none | mixed | contracting |
7/9 |
2/9 |
| Q3 2022 |
2022-12-13 |
D |
none | mixed | contracting |
7/9 |
2/9 |
| Q2 2022 |
2022-09-12 |
F |
withdrawn | mixed | contracting |
7/9 |
2/9 |
| Q1 2022 |
2022-06-09 |
D |
withdrawn | stable | contracting |
6/9 |
3/9 |
| Q3 2021 |
2021-12-09 |
C+ |
none | accelerating | expanding |
7/9 |
2/9 |
| Q2 2021 |
2021-09-09 |
C |
none | accelerating | expanding |
6/9 |
2/9 |
| Q1 2021 |
2021-06-10 |
D |
withdrawn | accelerating | expanding |
6/9 |
3/9 |
| Q4 2020 |
2021-04-29 |
D |
withdrawn | accelerating | contracting |
7/9 |
2/9 |
| Q3 2020 |
2020-12-21 |
D |
withdrawn | mixed | contracting |
7/9 |
4/9 |
| Q2 2020 |
2020-09-14 |
D |
withdrawn | mixed | contracting |
7/9 |
2/9 |
| Q1 2020 |
2020-06-16 |
D |
withdrawn | mixed | contracting |
7/9 |
3/9 |
| Q3 2019 |
2019-12-12 |
B |
none | accelerating | expanding |
7/9 |
2/9 |
| Q2 2019 |
2019-09-12 |
A |
raised | accelerating | expanding |
7/9 |
2/9 |
| Q1 2019 |
2019-06-13 |
C+ |
maintained | mixed | expanding |
7/9 |
2/9 |
| Q4 2018 |
2019-04-10 |
D |
maintained | mixed | expanding |
6/9 |
2/9 |
| Q3 2018 |
2018-12-13 |
B+ |
raised | accelerating | expanding |
6/9 |
1/9 |
| Q2 2018 |
2018-09-13 |
B+ |
raised | accelerating | expanding |
5/9 |
0/9 |
| Q1 2018 |
2018-06-14 |
B |
maintained | accelerating | expanding |
7/9 |
1/9 |
| Q4 2017 |
2018-04-12 |
B |
maintained | accelerating | expanding |
7/9 |
2/9 |
| Q2 2017 |
2017-09-07 |
D |
none | mixed | contracting |
7/9 |
2/9 |
| Q1 2017 |
2017-06-08 |
F |
none | mixed | expanding |
7/9 |
2/9 |
| Q4 2016 |
2017-04-28 |
F |
withdrawn | mixed | contracting |
7/9 |
5/9 |
| Q3 2016 |
2016-12-08 |
F |
lowered | slowing | expanding |
8/9 |
3/9 |
| Q2 2016 |
2016-09-08 |
F |
lowered | mixed | contracting |
7/9 |
3/9 |
| Q1 2016 |
2016-06-07 |
C+ |
maintained | mixed | contracting |
7/9 |
2/9 |
| Q4 2015 |
2016-03-29 |
D |
maintained | mixed | contracting |
8/9 |
4/9 |
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← VMW All “V” companies
VNDA →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.